Evotec expands compound management capability to US East Coast
Will open a new plant in Branford, Connecticut in the third quarter
Evotec (US) has signed a multi-year lease on a plant specifically designed to expand the company’s compound management services on the East Coast of the US.
The facility, located in Branford, Connecticut, will support Evotec’s drug discovery collaborators along the East Coast. The company said it would be ‘scalable for continued growth’.
The facility will be fully operational early in the third quarter and will complement Evotec’s existing facility in South San Francisco, which will continue to be fully operational.
Scott Snyder, Executive Vice President Compound Management of Evotec, said: ‘This is an important strategic expansion of our EVT Execute compound management offering which Evotec first acquired in South San Francisco in 2011. The significant investment will enable Evotec to compete better for East Coast compound management opportunities.’
No financial details have been revealed.
